Organization
Innoviva, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Innoviva, Inc.
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Commission has granted marketing authorisation ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive data from a study comparing a once-daily ...
... Innoviva, Inc. (NASDAQ: INVA) today announced that management will present at the following healthcare-focused ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive data from a study comparing a once-daily ...
... Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the third quarter ...
... Innoviva, Inc. (NASDAQ: INVA) announced today that it will report financial results for the ...
... If you want a Stock Review on FEYE, FTNT, INVA, or INTU then come over tohttp://dailystocktracker.com/register/and sign up for your free customized ...
... Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar,Innoviva'sPresident and Chief Executive Officer ...
... (NASDAQ: TBPH) ("Theravance Biopharma") today highlighted that GlaxoSmithKline plc (GSK) and Innoviva, Inc. (Innoviva) have reported positive headline results from the landmark Phase 3 IMPACT ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency's (EMA) Committee for ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the US Food and Drug Administration (FDA) ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced that the European Medicines Agency's (EMA) Committee for ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive results from the Salford Lung Study (SLS) ...
... 8, 2017, 6:35 PM EDT) -- An attorney for drug licensing company Innoviva Inc. warned Friday that Chancery Court could set a “dangerous precedent” if ...
... Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar,Innoviva'sPresident and Chief Executive Officer, ...
... Innoviva, Inc. (NASDAQ: INVA) today announced that Michael W. Aguiar,Innoviva'sPresident and Chief Executive Officer ...
... Innoviva, Inc. ("Innoviva" or the "Company") (NASDAQ: INVA) today announced the closing of a ...
... Innoviva, Inc. (NASDAQ: INVA) (the "Company" or "Innoviva") today announced that it closed its ...
... Innoviva, Inc. (NASDAQ: INVA) (the "Company" or "Innoviva") today announced its intention to offer, ...
... -- A Delaware vice chancellor pressed the CEO of biotech licensing firm Innoviva Inc. Thursday on the company’s last-minute walkaway from a director election deal ...
... Innoviva, Inc. (NASDAQ: INVA) (the Company) today reported financial results for the second quarter ...
... global production and commercialization of peptide antibiotics followed by Europe. Companies like Theravance and Vicuron Pharmaceuticals are the major American companies largely dedicated in the ...
... GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced a submission to the European Medicines Agency (EMA) ...
... Theravance Biopharma and Mylan are still on course to file for approval of ...
... Innoviva, Inc. (NASDAQ: INVA) announced today that it will report financial results for the ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤